Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.1K Hold
536
﹤0.01% 871
2026
Q1
$29.6K Hold
536
﹤0.01% 784
2025
Q4
$26.3K Buy
536
+236
+79% +$11K ﹤0.01% 877
2025
Q3
$12.9K Buy
+300
New +$11.7K ﹤0.01% 1006
2021
Q2
$51K Hold
1,030
﹤0.01% 380
2021
Q1
$45K Sell
1,030
-56
-5% -$2.54K ﹤0.01% 390
2020
Q4
$49K Sell
1,086
-421
-28% -$19.3K ﹤0.01% 372
2020
Q3
$70K Buy
+1,507
New +$75.5K 0.01% 319
2013
Q2
$560K Buy
+8,979
New +$570K 0.15% 134

Other funds holding GSK

First Horizon Corporation's GSK Position: Q2 2026 in Review

First Horizon Corporation held its GSK (GSK) position steady in Q2 2026 at 536 shares worth $28.1K. The position accounts for ﹤0.01% of the portfolio, ranked #871.

First Horizon Corporation first reported a position in GSK in Q2 2013 and has held it in 9 quarters since. The position peaked at $560K in Q2 2013. 475 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • First Horizon Corporation held 536 shares of GSK worth $28.1K as of Q2 2026.
  • First Horizon Corporation left its GSK share count unchanged in Q2 2026.
  • GSK made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #871 holding.
  • First Horizon Corporation first reported a position in GSK in Q2 2013 and has held it in 9 quarters since.
  • First Horizon Corporation's GSK position peaked at $560K in Q2 2013.
  • 475 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.